Are you Dr. Clancy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1600 Sw Archer Rd
Gainesville, FL 32610Phone+1 352-265-0606Fax+1 352-265-0678
Summary
- Dr. Cornelius Clancy, MD is an infectious disease specialist in Gainesville, Florida. He is currently licensed to practice medicine in Florida and Pennsylvania. He is affiliated with UPMC Presbyterian Shadyside.
Education & Training
University of FloridaFellowship, Infectious Disease, 1995 - 2000
MedStar Health (Baltimore)Residency, Internal Medicine, 1991 - 1994
Washington University in St. Louis School of MedicineClass of 1991
Certifications & Licensure
PA State Medical License 2011 - 2024
FL State Medical License Active through 2013- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Serial Therapeutic and Antifungal Monitoring Protocol Start of enrollment: 2014 Sep 01
- Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI) Start of enrollment: 2019 Aug 01
Publications & Presentations
PubMed
- A Global Call to Action to Fight Antimicrobial Resistance: IDSA and ESCMID Joint White Paper.Anurag N Malani, Mike Sharland, Cornelius J Clancy, Robert Skov
Open Forum Infectious Diseases. 2024-11-01 - 1 citationsInfluenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients.Simon Feys, Agostinho Carvalho, Cornelius J Clancy, Jean-Pierre Gangneux, Martin Hoenigl
The Lancet. Respiratory Medicine. 2024-09-01 - 1 citationsStewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock.Matthew O'Donnell, Ryan K Shields, Rachel V Marini, Lara M Groetzinger, Brian A Potoski
Open Forum Infectious Diseases. 2023-11-01
Press Mentions
Is Legislation to Safeguard Americans Against Superbugs a Boondoggle or Breakthrough?December 16th, 2022- W.H.O. Lists Top Fungal Health ThreatsOctober 26th, 2022
- Mike Doyle Pushing New Antibiotics Measure as He Approaches Congressional Career Finish LineAugust 28th, 2022
- Join now to see all
Grant Support
- The Candida Albicans Cell Wall Regulatory Network And PathogenesisNational Institute Of Dental &Craniofacial Research2010
- Identification Of In Vivo Induced A. Fumigatus AntigensNational Institute Of Allergy And Infectious Diseases2007–2008
- Identification Of In Vivo Induced A. Fumigatus AntigensNational Institute Of Allergy And Infectious Diseases2004–2007
- Oral And Vaginal Gene Expression By Candida During AIDSNational Institute Of Dental &Craniofacial Research2003–2004
- Phospholipase B: A Virulence Factor For Candida GlabrataNational Institute Of Allergy And Infectious Diseases2000–2002
